DSE/TECHNODRUG (DSE/TECHNODRUG)

Dhaka Stock Exchange: DSE/TECHNODRUG · BDT

BDT 33.5

+1.10 (+3.4%)· Recorded snapshot

Market cap	4.6B
Revenue (ttm)	3.1B
Net income (ttm)	202.4M
EPS (ttm)	BDT 1.53
Shares out	132M
P/E (trailing)	21.8x
Dividend	BDT 1.00 (2.98%)
Volume	611,416
Beta	0.22

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.1B
Net income (ttm): 202.4M
EPS (ttm): BDT 1.53
P/E (trailing): 21.8x
Market cap: 4.6B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E21.8

P25 n/aP50 n/aP75 n/a

ROE5

P25 n/aP50 n/aP75 n/a

ROIC7.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All DSE/TECHNODRUG indicators

Market & fundamental data

Available fields

190

Groups with data

Currency

BDT

Showing 190 of 190 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BDT
Country	Bangladesh
Country code	BD
Earnings date	2026-11-01
Employees	1,438
Employees change	-256
Employees growth	-15.11%
Enterprise value	BDT 7.3B
Exchange	Dhaka Stock Exchange
Financial currency	BDT
Financial report date	2026-03-31
First seen	2026-05-10
Fiscal year end	June
Founded	2009
Industry	Pharmaceutical Preparations
Is primary listing	Yes
ISIN number	BD0499TDL002
Last earnings date	2026-04-29
Last refreshed	2026-10-29
Market cap	BDT 4.6B
Next earnings date	2026-11-01
Price	BDT 33.50
Price currency	BDT
SIC code	2834
Stock price date	2026-10-28
Symbol	dse/TECHNODRUG
Website	https://www.technodrugsltd.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	4.58%
EV/Earnings	36.23x
EV/EBIT	10.62x
EV/EBITDA	6.7x
EV/Sales	2.36x
FCF / EV yield	-5.86%
FCF yield	-9.43%
Graham number	32.90383
Graham upside	-1.78%
Industry P/E	9.79x
P/B ratio	1.1x
P/E ratio	21.85x
P/OCF ratio	11.87x
P/S ratio	1.47x
Price / tangible book value	1.1x
Price/EBITDA ratio	4.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	22.27%
EBITDA margin	34.43%
Effective tax rate	23.65%
Gross margin	43.66%
Operating margin	22.27%
Pretax margin	8.55%
Profit margin	6.53%
Profit per employee	BDT 140,756
Revenue per employee	BDT 2.2M
ROA	5.77%
ROCE	10.22%
ROE	4.98%
ROIC	7.87%
Tax / revenue	2.02%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-14.93%
EPS growth (Q)	-7.2%
EPS growth (QoQ)	-24.52%
Gross profit growth	4.36%
Gross profit growth (Q)	-3.47%
Net income growth	-9.12%
Net income growth (Q)	-7.2%
Net income growth (QoQ)	-24.52%
OCF growth	124.41%
OCF growth (QoQ)	-46.23%
Operating income growth	19.61%
Operating income growth (Q)	4.47%
Revenue growth	-0.8%
Revenue growth (Q)	-7.29%
Revenue growth (QoQ)	-26.3%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BDT -813.2M
Depreciation and amortization	BDT 377.2M
EBIT	BDT 690.8M
EBITDA	BDT 1.1B
EPS	BDT 1.53
FCF per share	BDT -3.25
Financing cash flow	BDT 65.1M
Free cash flow	BDT -429.5M
Gross profit	BDT 1.4B
Income taxes	BDT 62.7M
Investing cash flow	BDT -791.2M
Net borrowing	BDT 117.7M
Net cash flow	BDT -342.4M
Net income	BDT 202.4M
Operating income	BDT 690.8M
Revenue	BDT 3.1B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.04
Book value per share	BDT 31.38
Debt / EBITDA	2.57
Debt / equity	0.68
Interest coverage	1.62
Long-term assets	BDT 4.8B
Long-term liabilities	BDT 2.6B
Net cash (debt)	BDT -2.8B
Net cash / market cap	-61.03%
Net debt / EBITDA	2.6
Net debt / equity	0.67
Piotroski F-Score	6
Property, plant and equipment	BDT 4.8B
Shareholders' equity	BDT 4.1B
Tangible book value	BDT 4.1B
Tangible book value per share	BDT 31.33
Total assets	BDT 7.6B
Total cash	BDT 38.5M
Total debt	BDT 2.8B
Total liabilities	BDT 3.5B
WACC	7.77%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.41
Current assets	BDT 2.9B
Current liabilities	BDT 877.3M
Current ratio	3.27
Inventory turnover	1.67
Net working capital	BDT 2.3B
Quick ratio	1.37
Working capital	BDT 2B
Working capital turnover	1.62

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-6.83%
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2026-01-25
Dividend payment years	2
Dividend payout frequency	Annual
Dividend per share	BDT 1.00
Dividend yield	2.99%
Ex-dividend date	2025-11-20
Last dividend	BDT 1.00
Payout ratio	21.17%
Shareholder yield	-3.85%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BDT 40.37
1D price change	3.4%
1M price change	-15.62%
1M total return	-15.62%
1W price change	0.6%
1W total return	0.6%
1Y price change	7.37%
1Y return CAGR	11.13%
1Y total return	11.13%
20-day SMA	BDT 34.98
200-day SMA	BDT 37.90
3M price change	-28.72%
3M total return	-28.72%
50-day SMA	BDT 39.30
50-day SMA vs 200-day SMA	50over200
52-week high	BDT 52.00
52-week high date	2026-07-20
52-week low	BDT 25.20
52-week low date	2025-11-16
6M price change	-5.37%
6M total return	-5.37%
All-time high	BDT 69.70
All-time high date	2024-08-04
All-time low	BDT 24.70
All-time low date	2024-07-14
Average true range (ATR)	BDT 1.64
Average volume	1.1M
Beta (1Y)	0.74
Beta (2Y)	0.45
Beta (5Y)	0.22
Change from 52-week high	-35.58%
Change from 52-week low	32.94%
Change from all-time high	-51.94%
Change from all-time low	35.65%
Change from open	3.4%
Day's gap	0%
Dollar volume	BDT 20.5M
High price	BDT 33.60
Low price	BDT 32.40
Monthly RSI	39
Open price	BDT 32.40
Position in 52-week range	91.67%
Previous close	BDT 32.40
Price vs 150-day SMA	-17.03%
Price vs 20-day SMA	-4.22%
Price vs 200-day SMA	-11.6%
Price vs 50-day SMA	-14.75%
Relative volume	0.57
RSI	45.04
Sharpe ratio	0.16
Sortino ratio	0.38
Volume	611.4K
Weekly RSI	0
YTD price change	15.12%
YTD total return	15.12%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	49.2M
Shares change (QoQ)	0%
Shares change (YoY)	6.83%
Shares held by insiders	62.72%
Shares outstanding	132M

Deeper analysis on DSE/TECHNODRUG

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this DSE/TECHNODRUG report

Is a complete DSE/TECHNODRUG research report available?

No complete published report is available for dse/TECHNODRUG (DSE/TECHNODRUG) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

DSE/TECHNODRUG (DSE/TECHNODRUG)

Price

Financial snapshot

Fair-value bridge

Latest news · DSE/TECHNODRUG

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All DSE/TECHNODRUG indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on DSE/TECHNODRUG

Frequently asked questions